CLINICAL_TRIALS
trial_result
· 2007-12-06
Clinical Trial Update: ATN-161 in Advanced Renal Cell Cancer [Phase 2]
Summary
A Phase 2 trial of ATN-161 for advanced renal cell carcinoma was terminated.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Attenuon | Conditions: Carcinoma, Renal Cell | Phase 2 | Status: TERMINATED